Concord Drugs Limited
Latest filings
- Concord Drugs 31st AGM: All 7 resolutions passed unanimously · Board & Shareholder Meetings
- Concord Drugs 31st AGM held on Sep 30, 2026 via video conferencing · Board & Shareholder Meetings
- Trading window closure for Q2 and H1 FY27 results · Compliance
Snapshot
What the business is, and whether it's a good one at a fair price.
A Pharmaceuticals & Biotechnology company listed on BSE, reporting revenue of ₹86 Cr over the trailing twelve months.
Scorecard
Measured from the filed financials, judged against its Pharmaceuticals peers · as of FY26 — not investment advice
Strengths
Nothing stands out in the filed numbers.Concerns
Charts
How has the market priced it — with filings on the timeline?
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Peers
How does it stack up on valuation, returns and growth?
Loading peers…
Financials
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Ownership
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Common questions
Answered from Concord Drugs Limited's filed financials and exchange disclosures
What does Concord Drugs Limited do?
Concord Drugs Limited is a Pharmaceuticals & Biotechnology company listed on BSE.
Is Concord Drugs Limited profitable?
Yes. Over the trailing twelve months Concord Drugs Limited reported a net profit of ₹2.05 Cr on revenue of ₹86 Cr.
Does Concord Drugs Limited pay a dividend?
Not in the latest reported year — Concord Drugs Limited's dividend payout for FY26 was nil.
Is Concord Drugs Limited debt-free?
No. It reported borrowings of ₹14 Cr on its 31 Mar 2026 balance sheet, or net debt of ₹13 Cr after cash. Debt stands at 0.28× equity. That is higher than 68% of its 166 Pharmaceuticals peers.
Is Concord Drugs Limited expensive compared with its peers?
On trailing P/E, Concord Drugs Limited ranks 93 of 158 in Pharmaceuticals — cheaper than 41% of them, against an industry median of 30.8×. This is a position, not a valuation judgement.
How much does the Concord Drugs Limited share price move in a day?
On a typical session Concord Drugs Limited moves 1.98% — that is the median absolute close-to-close move across its last 267 trading days. MarketPing measures each filing's price reaction against it.
Where can I track Concord Drugs Limited's announcements?
Every NSE and BSE filing by Concord Drugs Limited appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.